Notice2022-27690
Foreign-Trade Zone (FTZ) 61-San Juan, Puerto Rico; Notification of Proposed Production Activity, Boehringer Ingelheim Animal Health Puerto Rico LLC, (Pharmaceutical Products/Canine), Barceloneta, Puerto Rico
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
December 21, 2022
Issuing agencies
Commerce DepartmentForeign-Trade Zones Board
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 244 (Wednesday, December 21, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 244 (Wednesday, December 21, 2022)]
[Notices]
[Page 78045]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-27690]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-61-2022]
Foreign-Trade Zone (FTZ) 61--San Juan, Puerto Rico; Notification
of Proposed Production Activity, Boehringer Ingelheim Animal Health
Puerto Rico LLC, (Pharmaceutical Products/Canine), Barceloneta, Puerto
Rico
Boehringer Ingelheim Animal Health Puerto Rico LLC submitted a
notification of proposed production activity to the FTZ Board (the
Board) for its facility in Barceloneta, Puerto Rico within Subzone
61AC. The notification conforming to the requirements of the Board's
regulations (15 CFR 400.22) was received on December 13, 2022.
Pursuant to 15 CFR 400.14(b), FTZ production activity would be
limited to the specific finished product(s) described in the submitted
notification (summarized below) and subsequently authorized by the
Board. The benefits that may stem from conducting production activity
under FTZ procedures are explained in the background section of the
Board's website--accessible via <a href="http://www.trade.gov/ftz">www.trade.gov/ftz</a>. The proposed
finished product(s) would be added to the production authority that the
Board previously approved for the operation, as reflected on the
Board's website.
The proposed finished products include medicament that treats fleas
and ticks in finished (packaged) and semi-finished (unpackaged)
chewable tablets for canines (duty rate is duty-free).
Public comment is invited from interested parties. Submissions
shall be addressed to the Board's Executive Secretary and sent to:
<a href="/cdn-cgi/l/email-protection#b0d6c4caf0c4c2d1d4d59ed7dfc6"><span class="__cf_email__" data-cfemail="4e283a340e3a3c2f2a2b60292138">[email protected]</span></a>. The closing period for their receipt is January 30,
2023.
A copy of the notification will be available for public inspection
in the ``Online FTZ Information System'' section of the Board's
website.
For further information, contact Juanita Chen at
<a href="/cdn-cgi/l/email-protection#630916020d0a17024d000b060d2317110207064d040c15"><span class="__cf_email__" data-cfemail="c6acb3a7a8afb2a7e8a5aea3a886b2b4a7a2a3e8a1a9b0">[email protected]</span></a>.
Dated: December 15, 2022.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2022-27690 Filed 12-20-22; 8:45 am]
BILLING CODE 3510-DS-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on December 21, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.